Статті в журналах: "Priority diseases"

1

Kant, Lalit. "Diarrheal diseases research: Priority areas." Indian Journal of Pediatrics 59, no. 6 (November 1992): 655–56. http://dx.doi.org/10.1007/bf02859392.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Friedrich, M. J. "WHO’s Blueprint List of Priority Diseases." JAMA 319, no. 19 (May 15, 2018): 1973. http://dx.doi.org/10.1001/jama.2018.5712.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Morris, Kelly. "UN raises priority of non-communicable diseases." Lancet 375, no. 9729 (May 2010): 1859. http://dx.doi.org/10.1016/s0140-6736(10)60855-0.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Canning, David. "Priority setting and the ‘neglected’ tropical diseases." Transactions of the Royal Society of Tropical Medicine and Hygiene 100, no. 6 (June 2006): 499–504. http://dx.doi.org/10.1016/j.trstmh.2006.02.001.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Yankauer, A. "Sexually transmitted diseases: a neglected public health priority." American Journal of Public Health 84, no. 12 (December 1994): 1894–97. http://dx.doi.org/10.2105/ajph.84.12.1894.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Budde, Willi. "Healthcare funding: Rare diseases, a priority? AIM's proposals." Pharmaceuticals, Policy and Law 11, no. 4 (2009): 335–41. http://dx.doi.org/10.3233/ppl-2009-0227.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Kalaivani, A. "WHO R & D Priority Diseases: An Overview." Annals of SBV 7, no. 2 (2018): 46–47. http://dx.doi.org/10.5005/jp-journals-10085-7310.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Marinaccio, Alessandro, Alessandra Binazzi, Michela Bonafede, Antonella Altimari, Roberto Boscioni, Marisa Corfiati, Marta Clemente, and Adelina Brusco. "Occupational diseases in Italian national priority contaminated sites." American Journal of Industrial Medicine 61, no. 7 (June 11, 2018): 582–91. http://dx.doi.org/10.1002/ajim.22866.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Zarocostas, J. "Non-communicable diseases must have greater priority, says WHO." BMJ 339, jul14 1 (July 14, 2009): b2857. http://dx.doi.org/10.1136/bmj.b2857.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

The Lancet. "Making rare diseases a public-health and research priority." Lancet 371, no. 9629 (June 2008): 1972. http://dx.doi.org/10.1016/s0140-6736(08)60842-9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Akanmori, Bartholomew D., David O. Mukanga, Richard Mihigo, Michael Ward, Vincent Ahonkhai, and Matshidiso R. Moeti. "New development of medicines for priority diseases in Africa." Lancet 388, no. 10049 (September 2016): 1053–54. http://dx.doi.org/10.1016/s0140-6736(16)31544-6.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

12

Ndembi, Nicaise, Ngashi Ngongo, Mahlet Kifle Habtemariam, and Jean Kaseya. "Establishing self-sustaining vaccine manufacturing ecosystems: Africa’s priority diseases." Vaccine Insights 02, no. 11 (December 6, 2023): 435–40. http://dx.doi.org/10.18609/vac.2023.57.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

13

Ribeiro, Jonathan Nícolas dos Santos. "The Perception of Medical Students Regarding the Approach to Obesity as a Priority." Diabetes & Obesity International Journal 4, no. 4 (2019): 1–2. http://dx.doi.org/10.23880/doij-16000214.

Повний текст джерела

Анотація:

Obesity is a chronic disease and increasing incidence, studies reveal that treating and preventing seven of the top 10 killer diseases. Although much is published about the theme, there is a degree of ignorance on the part of the medical community about the treatment of obesity and its impact on chronic diseases. The present work investigated the medical student's view of the impact of obesity as a priority when dealing with related comorbidities. A survey was conducted, assessing the medical student's perception of the patient with obesity. Of a total of 377 students, 267 (70.82%) stated that other diseases such as diabetes and hypertension should be prioritized when evaluating the obese patient, while 110 (29.17%) stated that obesity should be prioritized. Based on the outcomes presented, it can be concluded that the perception of medical students regarding obesity approach still shows a predominance opinions that other diseases should be a priority over obesity.

Стилі APA, Harvard, Vancouver, ISO та ін.

14

Benerman, Henry. "Neglected Tropical Diseases: A Continuing Priority and a Lurking Threat." International Journal of Sciences 3, no. 07 (2017): 1–4. http://dx.doi.org/10.18483/ijsci.1311.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

15

Dorlo, T. P. C., R. M. Ravinetto, J. H. Beijnen, and M. Boelaert. "Commentary: Substandard medicines are the priority for neglected tropical diseases." BMJ 345, no. 14 1 (November 14, 2012): e7518-e7518. http://dx.doi.org/10.1136/bmj.e7518.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

16

Geneau, Robert, David Stuckler, Sylvie Stachenko, Martin McKee, Shah Ebrahim, Sanjay Basu, Arun Chockalingham, et al. "Raising the priority of preventing chronic diseases: a political process." Lancet 376, no. 9753 (November 2010): 1689–98. http://dx.doi.org/10.1016/s0140-6736(10)61414-6.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

17

Shrivastava, SaurabhRamBihariLal, and PrateekSaurabh Shrivastava. "World Health Organization releases the list of blueprint priority diseases." Journal of the Scientific Society 45, no. 1 (2018): 49. http://dx.doi.org/10.4103/jss.jss_8_18.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

18

Tebbens, Radboud J. Duintjer, and Kimberly M. Thompson. "Priority Shifting and the Dynamics of Managing Eradicable Infectious Diseases." Management Science 55, no. 4 (April 2009): 650–63. http://dx.doi.org/10.1287/mnsc.1080.0965.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

19

Marwick, C. "Effective response to emerging diseases called an essential priority worldwide." JAMA: The Journal of the American Medical Association 273, no. 3 (January 18, 1995): 189–90. http://dx.doi.org/10.1001/jama.273.3.189.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

20

Marwick, Charles. "Effective Response to Emerging Diseases Called an Essential Priority Worldwide." JAMA: The Journal of the American Medical Association 273, no. 3 (January 18, 1995): 189. http://dx.doi.org/10.1001/jama.1995.03520270023021.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

21

Vadjdi, Saghar, and Mojtaba Farjam. "Communicable Diseases and Non-Communicable Diseases: Which One Is the Priority in the Health Policies?" Galen Medical Journal 6, no. 1 (April 1, 2017): 1–2. http://dx.doi.org/10.31661/gmj.v6i1.851.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

22

Sharma, Nandita, Mahendra Singh, Yogesh Bahurupi, Suneela Garg, Om Prakash Bera, and Pradeep Aggarwal. "“75/25” Initiative for Hypertension: Setting Priority for Action." Indian Journal of Clinical Cardiology 4, no. 3 (September 2023): 175–78. http://dx.doi.org/10.1177/26324636231202922.

Повний текст джерела

Анотація:

The epidemiological shift and the increase in noncommunicable diseases (NCDs) have been of concern in recent times. Hypertension is the primary cause of 10.8% of all fatalities in India. The rapid increase in cardiovascular diseases, spurred on by poor lifestyle choices, is a serious concern. The increasing burden of chronic diseases is shown by data from the Indian Council of Medical Research, which assigns 61.8% of fatalities in 2016 to NCDs. According to data from the World Health Organization, NCDs account for 63% of fatalities in India, whereas CVDs account for 27% of fatalities. The National Program for Prevention and Control of Noncommunicable Diseases and the India Hypertension Control Initiative are the main initiatives being used by India to tackle hypertension and NCDs. Effective management is hampered by low levels of awareness in rural regions, treatment compliance issues, health disparities, and challenges with data collection and monitoring. Government programs and active youth participation are acknowledged as vital components to lower hypertension and pave the road for a healthier future. The Indian government also supports expanding outreach to underserved communities, encouraging better lives, providing telemedicine options, and enhancing data gathering and research for battling hypertension.

Стилі APA, Harvard, Vancouver, ISO та ін.

23

Horwood, Jennifer. "International pandemic influenza plans failing to set priority." Lancet Infectious Diseases 6, no. 12 (December 2006): 762–63. http://dx.doi.org/10.1016/s1473-3099(06)70645-4.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

24

The Lancet Infectious Diseases. "Vaccine against Zika virus must remain a priority." Lancet Infectious Diseases 17, no. 10 (October 2017): 1003. http://dx.doi.org/10.1016/s1473-3099(17)30534-0.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

25

File, Thomas M. "Pneumococcal Vaccination Remains a High Priority." Infectious Diseases in Clinical Practice 24, no. 1 (January 2016): 1–2. http://dx.doi.org/10.1097/ipc.0000000000000370.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

26

Osadcha, A. B., and T. V. Gavrys. "Priority area “Life sciences, new technologies of prevention and common diseases treatment”: financing and impact analysis." Science, technologies, innovation, no. 4(16) (2020): 34–42. http://dx.doi.org/10.35668/2520-6524-2020-4-04.

Повний текст джерела

Анотація:

In core foundation of the most important priority area of Ukraine “Life sciences, new technologies of prevention and common diseases treatment” are the current problems of modern Ukrainian society, labor productivity in all economy sectors. Rational distribution of funds and a high level of implementation of scientific (scientific and technical) outputs are the driving force of progressive technological structural changes in the economy and an important factor in ensuring the competitiveness of the national economy. The article presents the results of the author’s research on the state of implementation of one of the six priority areas defined by the Law of Ukraine “About Priority Areas of Science and Technology Development” for the period up to 2020, and 12 priority thematic areas of research, scientific and technical developments specified priority and approved by the Resolution of the Cabinet of Ministers of Ukraine from 07.09.2011 No. 942 for the period up to 2020 (as amended in accordance with the resolution of the Cabinet of Ministers of Ukraine from 23.08.2016 No. 556, which supplemented priority thematic areas list with new areas aimed at ensuring national security, increasing the state’s defense capabilities, protecting the civilian population, medicine, the agricultural sector, as well as clarifying the wording of a number of priority thematic areas).

Стилі APA, Harvard, Vancouver, ISO та ін.

27

Mortimer, Philip P. "Toward better pandemic planning: An urgent priority." Reviews in Medical Virology 30, no. 6 (July 28, 2020): 1–2. http://dx.doi.org/10.1002/rmv.2137.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

28

Sharma, Kalpa. "Burden of non communicable diseases in India: Setting priority for action." International Journal of Medical Science and Public Health 2, no. 1 (2013): 7. http://dx.doi.org/10.5455/ijmsph.2013.2.7-11.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

29

Pfeffer, Gerald, Sarah Jacob, and Jeffrey Preston. "COVID-19 Vaccine Priority for People With Neurologic and Rare Diseases." Journal of Neurology Research 11, no. 1-2 (April 2021): 1–4. http://dx.doi.org/10.14740/jnr665.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

30

Dovydenkova, M. V., and O. A. Artemeva. "Priority approaches to the diagnosis of viral diseases in cattle breeding." Veterinaria i kormlenie, no. 3 (2018): 16–18. http://dx.doi.org/10.30917/att-vk-1814-9588-2018-3-5.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

31

Bump, Jesse B., Michael R. Reich, and Anne M. Johnson. "Diarrhoeal diseases and the global health agenda: measuring and changing priority." Health Policy and Planning 28, no. 8 (November 27, 2012): 799–808. http://dx.doi.org/10.1093/heapol/czs119.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

32

Reed, Sharon L., and James H. McKerrow. "Why Funding for Neglected Tropical Diseases Should Be a Global Priority." Clinical Infectious Diseases 67, no. 3 (April 24, 2018): 323–26. http://dx.doi.org/10.1093/cid/ciy349.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

33

Raghav, Pankaja. "Strengthening occupational medicine to address challenges of occupational diseases: A priority." Indian Journal of Public Health 61, no. 3 (2017): 153. http://dx.doi.org/10.4103/ijph.ijph_267_17.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

34

Johnson, Anne M. "Outcomes in genitourinary medicine: whose priority?" International Journal of STD & AIDS 9, no. 1 (January 1, 1998): 9–15. http://dx.doi.org/10.1258/0956462981920964.

Повний текст джерела

Анотація:

Summary: The primary role of genitourinary medicine (GUM) services in the UK is the treatment and control of sexually transmitted diseases (STDs). The origins of the service lie in its public health function, yet measuring outcomes locally and nationally is not straightforward. Difficulties arise from the complex interactions between sexual behaviour, the biology of STDs and the role of clinical services; from the potential consequences of the National Health Service (NHS) internal market on national STD control; and from the limitations of information and surveillance systems. This paper considers each of these areas in turn and concludes with some proposals for measuring GUM outcomes locally and nationally which might potentially satisfy the concerns of commissioners and providers.

Стилі APA, Harvard, Vancouver, ISO та ін.

35

Parashar, Rakesh, Sharmishtha Nanda, Stephanie L. Smith, Zubin Shroff, Yusra R. Shawar, Dereck L. Hamunakwadi, and Jeremy Shiffman. "Comparing priority received by global health issues: a measurement framework applied to tuberculosis, malaria, diarrhoeal diseases and dengue fever." BMJ Global Health 9, no. 7 (July 2024): e014884. http://dx.doi.org/10.1136/bmjgh-2023-014884.

Повний текст джерела

Анотація:

IntroductionThe relative priority received by issues in global health agendas is subjected to impressionistic claims in the absence of objective methods of assessment of priority. To build an approach for conducting structured assessments of comparative priority health issues receive, we expand the public arenas model (2021) and offer a framework for future assessments of health issue priority in global and national health agendas.MethodsWe aimed to develop a more comprehensive set of measures for conducting multiyear priority comparisons of health issues in six agenda-setting arenas by identifying possible measures and data sources, selecting indicators based on feasibility and comparability of measures and gathering the data on selected indicators. We applied these measures to four communicable diseases—tuberculosis (TB), malaria, diarrhoeal diseases and dengue fever—given their differing impressionistic claims of priority. Where possible, we analysed the annual and/or 5-year trends from 2000 through 2022.ResultsWe observed that TB and malaria received the highest priority for most periods in the past two decades in most arenas. However, a stagnation in development funding for these two conditions over the last 8–10 years may have fuelled the neglect claims. Despite having a higher disease burden, diarrhoea has been slipping in global priority with reduced spending, fewer clinical trials and stagnating publications. Dengue remains a low-priority condition but has witnessed a sharp rise in attention from the pharmaceutical industry.DiscussionsWe expanded the arenas model by including a transnational arena (international representation) and additional measurements for various arenas. This analysis presents an approach to enable comparative trend analysis of the markers of agenda status over a multiyear period. More such analyses can bring much-desired objectivity in understanding how attention to global or national health issues changes over time in different arenas, potentiating a more equitable allocation of resources.

Стилі APA, Harvard, Vancouver, ISO та ін.

36

Bosone, Enrico, Giovanni Giuliani, Nicoletta Martone, Anna Ponzianelli, and Valeria Viola. "Timely Access to Priority Medicines in Europe." Medicine Access @ Point of Care 1 (January 2017): maapoc.0000021. http://dx.doi.org/10.5301/maapoc.0000021.

Повний текст джерела

Анотація:

Many tools have been developed in Europe to accelerate the access to and the availability of medicines. However, this is currently governed by the national Member State procedures for pricing and reimbursement. In many cases, this leads to procedures that often take many months or even years to be completed. This paper explores ways that would allow a more accelerated approach and thus enable a more efficient administrative procedure to be adopted. Therefore, this would favor the timely availability of medicines for severe diseases when an unmet medical need is present.

Стилі APA, Harvard, Vancouver, ISO та ін.

37

Brar, Gurcharn S., Thomas Fetch, Brent D. McCallum, Pierre J. Hucl, and Hadley R. Kutcher. "Virulence Dynamics and Breeding for Resistance to Stripe, Stem, and Leaf Rust in Canada Since 2000." Plant Disease 103, no. 12 (December 2019): 2981–95. http://dx.doi.org/10.1094/pdis-04-19-0866-fe.

Повний текст джерела

Анотація:

Wheat (Triticum spp.) is a major field crop in Canada in terms of acreage, annual production, and export market value. There are nine classes of Canadian wheat based on growth habit (winter or spring), kernel hardness (hard or soft), seed coat color (red or white), and quality factors (grain protein content and gluten strength). Wheat was described by Newman in 1928 as “the economic fairy to the industrial and commercial life of Canada, having built practically the whole economic structure of the Prairie Provinces.” Wheat production in Canada is affected by several biotic and abiotic stresses. The major abiotic stresses are frost damage, drought, and heat stress. Among biotic stresses, diseases caused by fungal pathogens are the most important although wheat streak mosaic virus (WSMV) has caused some localized outbreaks in some years. In context of cultivar registration in Canada, there are certain diseases that breeders have to take into account while developing resistant cultivars. The Prairie Recommending Committee for Wheat, Rye, and Triticale (PRCWRT) classify wheat diseases into priority one, priority two, and priority three depending on prevalence and potential damage they can cause. However, priority one diseases are more of a concern and a minimum level of resistance in commercial cultivars is recommended for those.

Стилі APA, Harvard, Vancouver, ISO та ін.

38

Malyutina, N. N., N. V. Isaeva, V. G. Kostarev, R. B. Eremeev, and S. V. Paramonova. "Priority directions of occupational medicine development in Perm Krai: challenges and realities." Perm Medical Journal 40, no. 5 (December 18, 2023): 115–20. http://dx.doi.org/10.17816/pmj405115-120.

Повний текст джерела

Анотація:

Objective. To analyze the priority directions of the development of occupational medicine in Perm Region. Materials and methods. Statistical data on morbidity and mortality from cardiovascular diseases in Russia, obtained from the Central Statistical Database of the Federal State Statistics Service, were analyzed. A literature review was performed. Results. Priority areas of occupational medicine in Perm Region are the following: preservation of workers' health, improvement of occupational medicine based on corporate health improvement programs. An important aspect is the assessment of specific working conditions, the identification of risk groups for the development of production-related and occupational diseases. Conclusions. It is necessary to take into account early signs of comorbidity of age-associated diseases, introduction of health-saving technologies and development of corporate programs.

Стилі APA, Harvard, Vancouver, ISO та ін.

39

Ridley, David B., Agustín Martín Lasanta, Ffion Storer Jones, and Sarah K. Ridley. "European priority review vouchers for neglected disease product development." BMJ Global Health 9, no. 1 (January 2024): e013686. http://dx.doi.org/10.1136/bmjgh-2023-013686.

Повний текст джерела

Анотація:

IntroductionNeglected diseases are a significant global health challenge. Encouraging the development of therapeutics and vaccines for these diseases would address an important unmet medical need. We propose a priority review voucher programme for the European Union (EU). The developer of a drug or vaccine for a neglected disease would receive a voucher for accelerated assessment of a different product at the European Medicines Agency (EMA).MethodsThis study uses retrospective observational data to estimate the potential commercial value of the proposed voucher programme using a five-step approach: (1) estimating the time saved in the EMA accelerated regulatory review; (2) gauging time reductions in accelerated pricing and reimbursement decisions by EU member states; (3) selecting 10 high-revenue products launched between 2015 and 2020 representing typical voucher users; (4) analysing IQVIA MIDAS sales data for the selected products and (5) calculating the net present value (NPV) of the voucher based on the 10 products.ResultsThe accelerated EMA review would reduce regulatory time by an average of 182 days. Additionally, products could save more than a year in many member states through an expedited 120-day pricing and reimbursement review. The estimated NPV of regulatory acceleration by two quarters would be €100 million. In addition, if France, Italy and Spain reviewed pricing and reimbursement in only 120 days, then the value would double.ConclusionAn EU voucher estimated at more than €100 million, coupled with a US$100 million counterpart, offers a meaningful incentive for novel product development. However, the voucher programme should be part of a comprehensive strategy for tackling neglected diseases, rather than a standalone solution.

Стилі APA, Harvard, Vancouver, ISO та ін.

40

Banerjee, Sayantan, DavidW Denning, and Arunaloke Chakrabarti. "One Health aspects & priority roadmap for fungal diseases : A mini-review." Indian Journal of Medical Research 153, no. 3 (2021): 311. http://dx.doi.org/10.4103/ijmr.ijmr_768_21.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

41

Dean, Elizabeth, Alison Greig, Sue Murphy, Robin Roots, Nadine Nembhard, Anne Rankin, Lesley Bainbridge, Joseph Anthony, Alison M. Hoens, and S. Jayne Garland. "Raising the Priority of Lifestyle-Related Noncommunicable Diseases in Physical Therapy Curricula." Physical Therapy 96, no. 7 (July 1, 2016): 940–48. http://dx.doi.org/10.2522/ptj.20150141.

Повний текст джерела

Анотація:

Abstract Given their enormous socioeconomic burdens, lifestyle-related noncommunicable diseases (heart disease, cancer, chronic lung disease, hypertension, stroke, type 2 diabetes mellitus, and obesity) have become priorities for the World Health Organization and health service delivery systems. Health care systems have been criticized for relative inattention to the gap between knowledge and practice, as it relates to preventing and managing noncommunicable diseases. Physical therapy is a profession that can contribute effectively to patients'/clients' lifestyle behavior changes at the upstream end of prevention and management. Efforts by entry-to-practice physical therapist education programs to align curricula with epidemiological trends toward best health care practices are varied. One explanation may be the lack of a frame of reference for reducing the knowledge translation gap. The purpose of this article is to provide a current perspective on epidemiological indicators and societal priorities to inform physical therapy curriculum content. Such content needs to include health examination/evaluation tools and health behavior change interventions that are consistent with contemporary values, directions, and practices of physical therapy. These considerations provide a frame of reference for curriculum change. Based on 5 years of experience and dialogue among curriculum stakeholders, an example of how epidemiologically informed and evidence-based best health care practices may be systematically integrated into physical therapy curricula to maximize patient/client health and conventional physical therapy outcomes is provided. This novel approach can serve as an example to other entry-to-practice physical therapist education programs of how to align their curricula with societal health priorities, specifically, noncommunicable diseases. The intentions are to stimulate dialogue about effectively integrating health-based competencies into entry-level education and advancing best practice, as opposed to simply evidence-based practice, across professions and health services and to establish accreditable, health promotion practice standards for physical therapy.

Стилі APA, Harvard, Vancouver, ISO та ін.

42

Rowley, Anne H. "Finding the Cause of Kawasaki Disease: A Pediatric Infectious Diseases Research Priority." Journal of Infectious Diseases 194, no. 12 (December 15, 2006): 1635–37. http://dx.doi.org/10.1086/509514.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

43

Fuster, Valentin, Janet Voute, Marilyn Hunn, and Sidney C. Smith. "Low Priority of Cardiovascular and Chronic Diseases on the Global Health Agenda." Circulation 116, no. 17 (October 23, 2007): 1966–70. http://dx.doi.org/10.1161/circulationaha.107.733444.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

44

Bavoria, Shalli, Sahil Langeh, and Lubna Ashraf Mir. "Food safety in India: a public health priority." International Journal Of Community Medicine And Public Health 8, no. 6 (May 25, 2021): 3193. http://dx.doi.org/10.18203/2394-6040.ijcmph20211917.

Повний текст джерела

Анотація:

Access to sufficient amounts of safe and nutritious food is the key to sustain life and promote good health. It is an essential component of our survival. Healthy and nutritious food leads to a healthy workforce and hence, improving the economy of any country. Unsafe food creates a vicious circle of disease and malnutrition, particularly affecting infants, young children, elderly and sick. The food borne diseases impede socioeconomic development of any country by increasing expenditure on health system and affecting national economies, tourism and trade. Food borne illnesses are usually caused by infectious organisms like bacteria, viruses, protozoa and toxins in chemicals which contaminate food, water and soil in which food is grown. These pathogens lead to diarrhoea and other deadly diseases like meningitis. In India, majority of the outbreaks of food borne disease are unreported, unrecognized or un-investigated and may only be noticed after major health or economic damage has occurred. In such a condition controlling the outbreaks, detection and removal of foods leading to the problem, identification of the factors that contribute to the contamination, growth, survival and dissemination of the suspected agent, prevention of future outbreaks and strengthening of food safety policies and programmes is not possible.

Стилі APA, Harvard, Vancouver, ISO та ін.

45

Fang, Hai, and Julian C. Knight. "Priority index: database of genetic targets in immune-mediated disease." Nucleic Acids Research 50, no. D1 (November 9, 2021): D1358—D1367. http://dx.doi.org/10.1093/nar/gkab994.

Повний текст джерела

Анотація:

Abstract We describe a comprehensive and unique database ‘Priority index’ (Pi; http://pi.well.ox.ac.uk) of prioritized genes encoding potential therapeutic targets that encompasses all major immune-mediated diseases. We provide targets at the gene level, each receiving a 5-star rating supported by: genomic evidence arising from disease genome-wide associations and functional immunogenomics, annotation evidence using ontologies restricted to genes with genomic evidence, and network evidence from protein interactions. Target genes often act together in related molecular pathways. The underlying Pi approach is unique in identifying a network of highly rated genes that mediate pathway crosstalk. In the Pi website, disease-centric pages are specially designed to enable the users to browse a complete list of prioritized genes and also a manageable list of nodal genes at the pathway crosstalk level; both switchable by clicks. Moreover, target genes are cross-referenced and supported using additional information, particularly regarding tractability, including druggable pockets viewed in 3D within protein structures. Target genes highly rated across diseases suggest drug repurposing opportunity, while genes in a particular disease reveal disease-specific targeting potential. To facilitate the ease of such utility, cross-disease comparisons involving multiple diseases are also supported. This facility, together with the faceted search, enhances integrative mining of the Pi resource to accelerate early-stage therapeutic target identification and validation leveraging human genetics.

Стилі APA, Harvard, Vancouver, ISO та ін.

46

van Assendelft, Alexander H. W. "Priority Classification of Patients According to a Modified ‘Norwegian Model’." International Journal of Technology Assessment in Health Care 12, no. 2 (1996): 395–401. http://dx.doi.org/10.1017/s0266462300009727.

Повний текст джерела

Анотація:

AbstractA priority classification was evaluated according to a modified “Norwegian model.” Many diseases do not belong to any specific priority category based only on the diagnosis. The classification also depends on the condition's type, site, and phase as well as the patient's age and overall condition. Savings cannot be achieved by the model used because 89% of the patients belonged to the priority categories I–III, the care of which can be classified as necessary.

Стилі APA, Harvard, Vancouver, ISO та ін.

47

Kuthyar, Sanjana, Casey L. Anthony, Tolulope Fashina, Steven Yeh, and Jessica G. Shantha. "World Health Organization High Priority Pathogens: Ophthalmic Disease Findings and Vision Health Perspectives." Pathogens 10, no. 4 (April 8, 2021): 442. http://dx.doi.org/10.3390/pathogens10040442.

Повний текст джерела

Анотація:

Recent Ebola epidemics, the ongoing COVID-19 pandemic, and emerging infectious disease threats have highlighted the importance of global infectious diseases and responses to public health emergencies. Ophthalmologists are essential health care workers who provide urgent and emergent vision care services during outbreaks and address the ocular consequences of epidemic and pandemic infectious diseases. In 2017, the World Health Organization (WHO) identified high priority pathogens likely to cause a future epidemic with the goal of guiding research and development to improve diagnostic tests, vaccines, and medicines. These measures were necessary to better inform and respond to public health emergencies. Given the ocular complications associated with emerging infectious diseases, there is a need to recognize the ophthalmic sequelae for future vision health preparedness for potential future outbreaks. The WHO High Priority pathogens list provides a roadmap for ophthalmologists and subspecialty providers that will guide strategic areas of research for clinical care and preparedness for future pandemic threats. This review summarizes these key viral pathogens, summarizes major systemic disease findings, and delineates relevant ocular complications of the WHO High Priority pathogens list, including Crimean-Congo hemorrhagic fever, Filovirus diseases (Ebola virus disease and Marburg hemorrhagic fever), human Coronaviruses, Lassa Fever, Nipah virus infection, Zika, and Rift Valley fever.

Стилі APA, Harvard, Vancouver, ISO та ін.

48

Faisel, A. "Migrant men: a priority for HIV control in Pakistan?" Sexually Transmitted Infections 82, no. 4 (August 1, 2006): 307–10. http://dx.doi.org/10.1136/sti.2005.018762.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

49

Lee, Cheryl Yi-Pin, and Lisa F. P. Ng. "Zika virus: from an obscurity to a priority." Microbes and Infection 20, no. 11-12 (December 2018): 635–45. http://dx.doi.org/10.1016/j.micinf.2018.02.009.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

50

Mendes Sá, Antonio Carlos Eber. "EDUCATION IN ORAL HEALTH: A Reflective Approach for Quality of Life." Brazilian Journal of Implantology and Health Sciences 2, no. 8 (July 24, 2020): 73–85. http://dx.doi.org/10.36557/2674-8169.2020v2n8p73-85.

Повний текст джерела

Анотація:

This work aims at critical reflection on the actions that determine a good level of oral health. Health promotion is a process that can positively affect the quality of life of a population. Dental problems have a low priority compared to diseases considered to be of social relevance. Prevention of oral diseases must be developed at three levels: primary, secondary and tertiary. Self-diagnosis is extremely important, because the sooner the problem is detected and prevention services are activated, the greater the chances of an effective treatment. Among oral health problems, dental caries is considered a damage that deserves higher priority due to its high prevalence. Oral cancer gained the second degree of priority, due to its severity, followed by periodontal diseases. Education in oral health has been increasingly required, taking into account the low cost and the possibilities of dental impact on public health. Therefore, the role of educating should not be the exclusive responsibility of the professional conventionally called teacher, but of any citizen.

Стилі APA, Harvard, Vancouver, ISO та ін.

Статті в журналах з теми "Priority diseases"

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями